Nutrition literacy in head and neck cancer survivors and their caregivers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This cross-sectional observational project enrolls post-treatment head and neck cancer survivors (6 months–4 years after primary treatment) paired with an informal caregiver who helps with food shopping or preparation. Participants complete questionnaires measuring nutrition literacy and sociodemographic and behavioral characteristics, and undergo measurements including skin carotenoid levels, body composition, and functional status alongside quality-of-life surveys. Data from survivor-caregiver dyads will be analyzed to explore how individual and shared nutrition knowledge correlates with objective nutrition markers and patient-reported outcomes. Results aim to identify patterns that could guide tailored nutrition education or supportive services for survivors and their caregivers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Survivors and their caregivers will be eligible to participate if the survivor 1) has a history of oral cavity, pharyngeal, or laryngeal cancer, 2) is between 6 months - 4 years post-primary oncology treatment, 3) has no evidence of disease, 4) has an informal caregiver living in or out of the home who has a shared or primary role in food procurement and/or preparation, 5) no current use of feeding tube as the primary source of nutrition and can consume food orally, 6) age 18+, 7) English-speaking. Survivors and their caregivers will not be eligible to participate if either has 1) dementia or organic brain syndrome; 2) severe emotional distress; 3) active schizophrenia, 4) another diagnosis of cancer in the past five years (not including skin or cervical cancer in situ).

Exclusion Criteria:

* Adults unable to consent
* Individuals who are not yet adults (infants, children, teenagers)
* Pregnant women
* Prisoners

Where it's running

• University of Kansas Medical Center
  Kansas City, Kansas, United States Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• A program to support head and neck cancer survivors and their caregivers

  This study is testing a new support program for head and neck cancer survivors and their caregivers to see if it helps them manage symptoms and reduces stress compared to regular care.

  Recruiting Medical University of South Carolina · Charleston, South Carolina · NCT05811936

• Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)

  This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.

  Recruiting Phase 2 Shaukat Khanum Memorial Cancer Hospital & Research Centre · Lahore, Punjab Province · NCT07919444

• Airway ultrasound in head and neck cancer patients

  This observational study tests whether neck ultrasound measurements of the airway match CT measurements in adults with maxillofacial cancer undergoing surgery with anesthesia.

  Recruiting at 2 sites University Hospital Dubrava · Zagreb, City of Zagreb and 1 other locations · NCT07910149

• Safe use of metformin and naproxen to help prevent cancer in people with Fanconi anemia

  This study tests whether metformin and naproxen can lower the chance of cancer developing in adults with Fanconi anemia.

  Recruiting at 2 sites Phase 1 Rockefeller University · Minneapolis, Minnesota and 1 other locations · NCT07901959

• Effects of immersive VR, non-immersive VR, and 3D-printed models on anatomy learning

  This study tests whether immersive VR, non-immersive VR, or 3D-printed models help college students learn anatomy and handle cognitive load.

  Recruiting Abant Izzet Baysal University · Bolu, Merkez · NCT07886970

• Iparomlimab and Tuvonralimab With Cetuximab Before Surgery in Resectable Oral Cancer

  In this phase 2 study, patients with locally advanced, resectable oral squamous cell carcinoma will receive a combination of iparomlimab, tuvonralimab, and cetuximab before surgery to see if the treatment is safe and can shrink tumors.

  Recruiting Phase 2 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Shanghai, Shanghai Municipality · NCT07882888

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.